• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
US Cardiac Device Market Analysis Product Image

US Cardiac Device Market Analysis

  • ID: 2192684
  • July 2012
  • Region: United States
  • 75 Pages
  • RNCOS E-Services Private Limited

FEATURED COMPANIES

  • C. R. Bard, Inc
  • Cordis Corporation
  • Medtronic
  • SonoSite, Inc.
  • St. Jude Medical
  • Teleflex Incorporated
  • MORE

The higher prevalence of cardiovascular diseases has become a cause of concern for the US healthcare authorities as mortalities tend to rise and economic burden keep increasing. It is estimated that the country has around 80 Million persons living with cardiovascular diseases and the total direct cost associated with the disease is to the tune of around US$ 314 Billion. To gauge the disease burden, RNCOS’s new research, “US Cardiac Device Market Analysis”, offers comprehensive insight into the prevalence of cardiovascular diseases in the US, mortality by disease areas, number of procedures performed and their mean cost.

The market for cardiac medical devices in the US is one of the most prominent healthcare segments in the country as aging population and the demand for innovative treatment options are consistently boosting the market. We project that this lucrative market is likely to register a CAGR of around 9% during 2012-2015. In this context, the report effectively analyzes the current market size and key drivers. It also provides the forecast for the overall market and its key segments namely: cardiac rhythm management, interventional cardiology and cardiovascular READ MORE >

FEATURED COMPANIES

  • C. R. Bard, Inc
  • Cordis Corporation
  • Medtronic
  • SonoSite, Inc.
  • St. Jude Medical
  • Teleflex Incorporated
  • MORE

1. Analyst View

2. Research Methodology

3. US Cardiac Medical Device Market Outlook
3.1 Current and Future Analysis to 2015
3.1.1 Cardiac Rhythm Management
3.1.2 Interventional Cardiology
3.1.3 Cardiac Surgery

4. Regulatory Landscape

5. Competitive Assessment

5.1 Boston Scientific Corporation
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Strengths & Weaknesses
5.1.4 Key Developments

5.2 Cordis Corporation
5.2.1 Business Overview
5.2.2 Strengths and Weaknesses
5.2.3 Key Developments

5.3 St. Jude Medical
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Strengths and Weaknesses
5.3.4 Key Developments

5.4 Medtronic
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Strengths and Weaknesses
5.4.4 Key Developments

5.5 C. R. Bard, Inc
5.5.1 Business Overview
5.5.2 Financial Overview
5.5.3 Strengths and Weaknesses
5.5.4 Key Developments

5.6 Edwards Lifesciences Corporation
5.6.1 Business Overview
5.6.2 Financial Overview
5.6.3 Strengths and Weaknesses
5.6.4 Key Developments

5.7 Teleflex Incorporated
5.7.1 Business Overview
5.7.2 Financial Overview
5.7.3 Strengths and Weaknesses
5.7.4 Key Developments

5.8 Zoll Medical Corporation
5.8.1 Business Overview
5.8.2 Financial Overview
5.8.3 Strengths and Weaknesses
5.8.4 Key Developments

5.9 Thoratec Corporation
5.9.1 Business Overview
5.9.2 Financial Overview
5.9.3 Strengths and Weaknesses
5.9.4 Key Developments

5.10 SonoSite, Inc.
5.10.1 Business Overview
5.10.2 Financial Overview
5.10.3 Strengths and Weaknesses
5.10.4 Key Developments

List of Tables

Table 3-1: Prevalence of Cardiovascular Diseases (Million)
Table 3-2: Number of Cardiovascular Procedures and Mean Cost (US$)
Table 5-1: Boston Scientific - Key Products
Table 5-2: Boston Scientific - Financial Performance (Million US$), 2009-2011
Table 5-3: Cordis Corporation - Key Products
Table 5-4: St. Jude Medical - Key Products
Table 5-5: St. Jude Medical - Financial Performance (Million US$), 2009-2011
Table 5-6: Medtronic - Key Products
Table 5-7: Medtronic - Financial Performance (Million US$), 2009-2011
Table 5-8: C. R. Bard - Key Products
Table 5-9: C. R. Bard - Financial Performance (Million US$), 2009-2011
Table 5-10: Edwards Lifesciences Corporation - Key Products
Table 5-11: Edward LifeSciences Corporation - Financial Performance (Million US$), 2009-2011
Table 5-12: Teleflex - Key Products
Table 5-13: Teleflex - Financial Performance (Million US$), 2009-2011
Table 5-14: Zoll Medical Corporation - Key Products
Table 5-15: Zoll Medical Corporation - Financial Performance (Million US$), 2009-2011
Table 5-16: Thoratec Corporation - Key Products
Table 5-17: Thoratec Corporation - Financial Performance (Million US$), 2009-2011
Table 5-18: Sonosite - Key Products
Table 5-19: SonoSite - Financial Performance (Million US$), 2009-2011

List of Charts

Figure 3-1: Deaths from Cardiovascular Diseases (%)
Figure 3-2: Cardiac Devices Market (Billion US$), 2011-2015
Figure 3-3: Cardiac Devices Market by Segment (%), 2011
Figure 3-4: Cardiac Rhythm Management Devices Market (Billion US$), 2011-2015
Figure 3-5: Cardiac Rhythm Management Devices Market by Segment (%), 2011
Figure 3-6: Interventional Cardiology Devices Market (Billion US$), 2011-2015
Figure 3-7: Interventional Cardiology Devices Market by Segment (%), 2011
Figure 3-8: Cardiovascular Surgery Devices Market (Billion US$), 2011-2015
Figure 3-9: Cardiovascular Surgery Devices Market by Segment (%), 2011

- Boston Scientific Corporation

- Cordis Corporation

- St. Jude Medical

- Medtronic

- C. R. Bard, Inc

- Edwards Lifesciences Corporation

- Teleflex Incorporated

- Zoll Medical Corporation

- Thoratec Corporation

- SonoSite, Inc.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos